Refine by
Cell Line And Vector Development Articles & Analysis
15 news found
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology ...
In this free webinar, learn about the importance of early glycan screening for ensuring biologic quality, and how automation reduces time-to-insight and improves workflow efficiency. The featured speakers will share real-world applications and results from glycan screening success. Attendees will learn how to integrate automated glycan profiling into cell line development (CLD) labs. Early ...
Introduction We recently sat down with one of our valued customers, Dr Alexis Rossignol (Clean Cells), to discuss his experience with VIPS PRO, our cutting-edge technology designed to streamline and enhance the early stages of cell line development. This interview provides insight into Clean Cells’ quest to automate and increase single-cell seeding while having undisputable proof ...
ExcellGene SA, a leading Swiss biotech service provider specializing in mammalian cell line development for more than two decades, proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization (CDMO) based in the USA. As CHO (Chinese Hamster Ovary) and HEK (Human Embryonic Kidney) cells are the most well-suited mammalian ...
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug development processes, driving down development costs and enabling an improved output. The protocols will be available for use on the BIO CELLX system ...
ByCELLINK
LOTTE BIOLOGICS and EXCELLGENE today announced the signing of a Memorandum of Understanding to collaborate in the biopharmaceutical Contract Development Organization (CDO) business. With this agreement, LOTTE BIOLOGICS will be able to proactively promote its CDO business by attracting a large number of customers ahead of its long-term strategy of expanding its Syracuse plant and constructing a ...
Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide. Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug development and drug ...
MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the development of a new in vitro kidney model. MatTek Life Sciences, a Boston-area tissue engineering company and a member of the BICO Group, announced today it has entered into a distribution agreement and strategic partnership with Cell4Pharma, a Netherlands-based company specializing ...
This month ARTES Biotechnology celebrates its 20th anniversary. The whole team is very thrilled and we think it is time to give a small overview on company’s history. In 2002 at May 10th Michael Piontek founded ARTES as a one-man operation executing and taking care of two license deals as part of a severance agreement. He was absolute sure that this will be an interim solution only while ...
JSR Life Sciences, LLC (JSR) today announced that Mark W. Womack will serve as the Chief Executive Officer of two of its affiliate companies: KBI Biopharma, a leading global CDMO specializing in drug development and biologics manufacturing, and Selexis SA, an industry-leading cell line development provider. Womack will be responsible for the strategic vision, continued growth, and organizational ...
Handed to products that excel in their design and vision, the iF awards are voted on by a jury of 132 leading designers from across the globe with the goal to identify products which demonstrate the adoption of modern design trends and outstanding craftsmanship. For the third year in a row, BICO has taken home the award and extends its haul to 11 iF design awards in total, officially ranking ...
MatTek Life Sciences will produce and distribute EpiOral from its production facility in Slovakia, continuing the BICO groups’ focus on providing on-demand tissues to the European market. MatTek Life Sciences, a Boston-area tissue engineering company and a part of the BICO Group, announced today its European facility in Bratislava, Slovakia, will begin producing and shipping EpiOral, a ...
Oxford, United Kingdom, 07 March, 2022: Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry. Orbit will combine its leading peptide discovery platform and experience with WuXi ...
-Accelerating for development of high expression cell line through combination of GI-SMARTTM platform technology of GI Innovation and CHOZN® Platform of Merck -Expecting synergy of both companies for biopharmaceutical development using CHOZN® Platform, supplying subsidiary materials, education consulting, and etc.,. GI Innovation Co., Ltd. announced that it signed MoU for a ...
BIO DIGITAL 2021 – New and emerging biopharma companies working on early development can now leverage a better lab to clinic drug development solution designed to accelerate the journey from DNA to drug product. The enhanced Quick to Clinic solution from Thermo Fisher Scientific may help biopharma companies reach Phase I/First-In-Human trials and file for Investigational New Drug (IND) ...